The South Korean units of McDonald's, Burger King, and KFC are facing growing skepticism over finding new owners for their franchises here, due to increased difficulties in fundraising and a growing preference among domestic consumers for healthier foods.
According to a food and beverage franchise buyout expert, the pool of buyers who can afford higher prices has become smaller because interest rate hikes have worsened the condition of the acquisition financing market.
He added that the chains' valuations will also be impacted by the concurrent sales attempts.
To avoid harsher market conditions next year, Korean fast-food franchise owners must sell their businesses this year.
Fast food restaurants face significant risks from rising labor and ingredient expenses because it is challenging to raise prices to cover these costs.
The snowballing losses in the fried chicken and hamburger business cost KFC's Korean operator KG Group, which led to a capital impairment in 2020.
KG Group is reportedly desperate to sell the KFC franchise for about 100 billion won, to secure enough cash to buy SsangYong Motor.
Following a failed attempt in 2016, McDonald's US headquarters launched another attempt to sell its Korean business.
However, prospective buyers objected to the conditions of the deal.
Operating losses for McDonald's Korea amounted to 44 billion won in 2019, 48,3 billion won in 2020, and 27.7 billion won in 2021.
The operator of Burger King's Korean location, Affinity Equity Partners, is thought to be more in need of a quick sale because it is a PEF and is required to quickly sell its portfolio companies to disperse profits to its investors.
The Hong Kong-based PEF has been attempting to sell the Burger King's Korean unit in 2016 and its Japanese counterpart for a combined 1 trillion won since late last year.
Insiders in the M&A market, however, expressed doubt about the hamburger business being purchased by a PEF and noted that it will be challenging to increase its valuation until divestiture.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure 



